Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Total Valuation
Elanco Animal Health has a market cap or net worth of $11.58B. The enterprise value is $13.52B.
Market Cap$11.58B
Enterprise Value$13.52B
Share Statistics
Elanco Animal Health has 496,863,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding496,863,460
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Elanco Animal Health’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 1.53%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)1.53%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee493.22K
Profits Per Employee37.56K
Employee Count9,000
Asset Turnover0.35
Inventory Turnover1.61
Valuation Ratios
The current PE Ratio of Elanco Animal Health is 319.8. Elanco Animal Health’s PEG ratio is -0.14.
PE Ratio319.8
PS Ratio1.35
PB Ratio0.98
Price to Fair Value0.98
Price to FCF15.18
Price to Operating Cash Flow16.97
PEG Ratio-0.14
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.44B and earned 338.00M in profits. Earnings per share was 0.68.
Revenue4.44B
Gross Profit1.91B
Operating Income251.00M
Pretax Income488.00M
Net Income338.00M
EBITDA1.49B
Earnings Per Share (EPS)0.68
Cash Flow
In the last 12 months, operating cash flow was 629.00M and capital expenditures -267.00M, giving a free cash flow of 362.00M billion.
Operating Cash Flow629.00M
Free Cash Flow362.00M
Free Cash Flow per Share0.73
Dividends & Yields
Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change76.46%
50-Day Moving Average21.14
200-Day Moving Average15.19
Relative Strength Index (RSI)64.08
Average Volume (3m)5.46M
Important Dates
Elanco Animal Health upcoming earnings date is Feb 25, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
Elanco Animal Health as a current ratio of 2.44, with Debt / Equity ratio of 59.62%
Current Ratio2.44
Quick Ratio1.25
Debt to Market Cap0.72
Net Debt to EBITDA2.67
Interest Coverage Ratio0.74
Taxes
In the past 12 months, Elanco Animal Health has paid 150.00M in taxes.
Income Tax150.00M
Effective Tax Rate0.31
Enterprise Valuation
Elanco Animal Health EV to EBITDA ratio is 6.69, with an EV/FCF ratio of 25.27.
EV to Sales2.24
EV to EBITDA6.69
EV to Free Cash Flow25.27
EV to Operating Cash Flow18.41
Balance Sheet
Elanco Animal Health has $505.00M in cash and marketable securities with $4.02B in debt, giving a net cash position of -$3.52B billion.
Cash & Marketable Securities$505.00M
Total Debt$4.02B
Net Cash-$3.52B
Net Cash Per Share-$7.08
Tangible Book Value Per Share-$4.05
Margins
Gross margin is 46.37%, with operating margin of 5.65%, and net profit margin of 7.61%.
Gross Margin46.37%
Operating Margin5.65%
Pretax Margin10.99%
Net Profit Margin7.61%
EBITDA Margin33.54%
EBIT Margin18.63%
Analyst Forecast
The average price target for Elanco Animal Health is $25.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$25.13
Price Target Upside7.81% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast3.08%
EPS Growth Forecast-82.39%